Table 3 |
|||
|
Multivariate analysis of independent prediction of silent liver fibrosis |
|||
|
Odds ratio |
95% Confidentialinterval |
P-value |
|
|
|
|||
|
Laboratory variables |
|||
|
Gamma-glutamyltranspeptidase, IU/L |
1.009 |
0.953, 1.068 |
0.757 |
|
Cumulative dose of medications, mg |
|||
|
Leflunomide (53 patients) |
1.000 |
1.000, 1.000 |
0.007 |
|
Prednisolone (89 patients) |
1.000 |
1.000, 1.000 |
0.547 |
|
|
|||
|
Lee et al. Arthritis Research & Therapy 2012 14:R232 doi:10.1186/ar4075 |
|||
